Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
NCT04374565
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Corona Virus Infection
SARS-CoV 2
SARS Pneumonia
Pneumonia
Interventions
DRUG:
High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
Sponsor
University of Virginia